CRNX
Price
$32.10
Change
+$0.22 (+0.69%)
Updated
Jun 3 closing price
Capitalization
3.01B
65 days until earnings call
DYN
Price
$13.27
Change
+$0.57 (+4.49%)
Updated
Jun 3 closing price
Capitalization
1.51B
57 days until earnings call
Interact to see
Advertisement

CRNX vs DYN

Header iconCRNX vs DYN Comparison
Open Charts CRNX vs DYNBanner chart's image
Crinetics Pharmaceuticals
Price$32.10
Change+$0.22 (+0.69%)
Volume$679.69K
Capitalization3.01B
Dyne Therapeutics
Price$13.27
Change+$0.57 (+4.49%)
Volume$1.75M
Capitalization1.51B
CRNX vs DYN Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. DYN commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and DYN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (CRNX: $32.10 vs. DYN: $13.27)
Brand notoriety: CRNX and DYN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 67% vs. DYN: 66%
Market capitalization -- CRNX: $3.01B vs. DYN: $1.51B
CRNX [@Biotechnology] is valued at $3.01B. DYN’s [@Biotechnology] market capitalization is $1.51B. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileDYN’s FA Score has 1 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • DYN’s FA Score: 1 green, 4 red.
According to our system of comparison, DYN is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 5 TA indicator(s) are bullish while DYN’s TA Score has 6 bullish TA indicator(s).

  • CRNX’s TA Score: 5 bullish, 3 bearish.
  • DYN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CRNX and DYN are a good buy in the short-term.

Price Growth

CRNX (@Biotechnology) experienced а +8.81% price change this week, while DYN (@Biotechnology) price change was +13.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

DYN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.01B) has a higher market cap than DYN($1.51B). CRNX YTD gains are higher at: -37.219 vs. DYN (-43.676). CRNX has higher annual earnings (EBITDA): -373.49M vs. DYN (-395.31M). CRNX has more cash in the bank: 1.27B vs. DYN (677M). DYN has less debt than CRNX: DYN (23.3M) vs CRNX (50.8M). CRNX has higher revenues than DYN: CRNX (760K) vs DYN (0).
CRNXDYNCRNX / DYN
Capitalization3.01B1.51B199%
EBITDA-373.49M-395.31M94%
Gain YTD-37.219-43.67685%
P/E RatioN/AN/A-
Revenue760K0-
Total Cash1.27B677M188%
Total Debt50.8M23.3M218%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
51
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXDYN
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
79%
Bearish Trend 22 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIDFX26.250.05
+0.19%
American Funds Income Fund of Amer R5
PCBCX10.99N/A
N/A
Victory Pioneer Balanced C
IGMSX8.33N/A
N/A
Voya Global Insights Portfolio S
JSEPX38.57N/A
N/A
JPMorgan Small Cap Equity R3
HFSIX15.15N/A
N/A
Hartford Schroders Intl Cntrrn Val I

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+0.69%
XNCR - CRNX
58%
Loosely correlated
+6.53%
IDYA - CRNX
56%
Loosely correlated
+1.98%
DYN - CRNX
56%
Loosely correlated
+4.49%
TRDA - CRNX
55%
Loosely correlated
+1.23%
RVMD - CRNX
55%
Loosely correlated
-0.17%
More

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+4.49%
CRNX - DYN
56%
Loosely correlated
+0.69%
RNA - DYN
52%
Loosely correlated
+3.74%
XNCR - DYN
51%
Loosely correlated
+6.53%
ERAS - DYN
51%
Loosely correlated
+1.40%
RVMD - DYN
50%
Loosely correlated
-0.17%
More